Overview
Efferent Labs CMO, Dr. Spencer Rosero, was invited to present the findings and efforts of Efferent Labs work in collaboration with Evotec A.G. at the ESC Congress 2019 together with the World Congress of Cardiology from 31 August to 4 September at the Expo Porte de Versailles in Paris, France.
Background
21st century health care remains anchored to sporadic measurements of
traditional physiologic variables such as heart rate, blood pressure, weight,
physical exam findings and general biochemical values. Currently there is
no sensor capable of monitoring in intra-cellular protein and gene level
signaling in real-time and in-vivo. This gap between biological signaling
and its translation into clinically relevant therapeutics targeting the
individual has limited precision medicine approaches to heart and vascular
diseases. Inflammatory processes have been implicated in numerous
cardiovascular diseases providing an ideal target for using Biologically
based-Implantable Electronic Devices (BIED) approaches.
See more at: https://academic.oup.com/eurheartj/article/40/Supplement_1/ehz746.0905/5596757?login=true
